Brief: NS Pharma Says Viltepso (Viltolarsen) Injection Now Commercially Available In U.S.
19/08/2020 22:39
Aug 19 (Reuters) - Nippon Shinyaku Co Ltd 4516.T :
* NS PHARMA - VILTEPSO (VILTOLARSEN) INJECTION NOW
COMMERCIALLY
AVAILABLE IN U.S.
Source text for Eikon: ID:nPn7T0bSa
Further company coverage: 4516.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nippon Shinyaku
See all newsTable: Nippon Shinyaku -Q1 group results (IFRS)
Brief: Elixirgen Therapeutics And Nippon Shinyaku Enter Into An Option Agreement For The Development And Commercialization Of Exg-7001 For Duchenne Muscular Dystrophy
Table: Nippon Shinyaku -2025/26 group results (IFRS)
Table: Nippon Shinyaku -2025/26 parent results
Table: Nippon Shinyaku -9-MTH group results (IFRS)